Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
Titel:
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
Auteur:
Rossi, David Dennetta, Donatella Ugolini, Marcello Catalano, Vincenzo Alessandroni, Paolo Giordani, Paolo Baldelli, Anna Maria Casadei, Virginia Graziano, Francesco Luzi Fedeli, S.